Regular Article
Somatostatin and Its Receptor Family

https://doi.org/10.1006/frne.1999.0183Get rights and content

Abstract

Somatostatin (SST), a regulatory peptide, is produced by neuroendocrine, inflammatory, and immune cells in response to ions, nutrients, neuropeptides, neurotransmitters, thyroid and steroid hormones, growth factors, and cytokines. The peptide is released in large amounts from storage pools of secretory cells, or in small amounts from activated immune and inflammatory cells, and acts as an endogenous inhibitory regulator of the secretory and proliferative responses of target cells that are widely distributed in the brain and periphery. These actions are mediated by a family of seven transmembrane (TM) domain G-protein-coupled receptors that comprise five distinct subtypes (termed SSTR1–5) that are endoded by separate genes segregated on different chromosomes. The five receptor subtypes bind the natural SST peptides, SST-14 and SST-28, with low nanomolar affinity. Short synthetic octapeptide and hexapeptide analogs bind well to only three of the subtypes, 2, 3, and 5. Selective nonpeptide agonists with nanomolar affinity have been developed for four of the subtypes (SSTR1, 2, 3, and 4) and putative peptide antagonists for SSTR2 and SSTR5 have been identified. The ligand binding domain for SST ligands is made up of residues in TMs III–VII with a potential contribution by the second extracellular loop. SSTRs are widely expressed in many tissues, frequently as multiple subtypes that coexist in the same cell. The five receptors share common signaling pathways such as the inhibition of adenylyl cyclase, activation of phosphotyrosine phosphatase (PTP), and modulation of mitogen-activated protein kinase (MAPK) through G-protein-dependent mechanisms. Some of the subtypes are also coupled to inward rectifying K+ channels (SSTR2, 3, 4, 5), to voltage-dependent Ca2+ channels (SSTR1, 2), a Na+/H+ exchanger (SSTR1), AMPA/kainate glutamate channels (SSTR1, 2), phospholipase C (SSTR2, 5), and phospholipase A2 (SSTR4). SSTRs block cell secretion by inhibiting intracellular cAMP and Ca2+ and by a receptor-linked distal effect on exocytosis. Four of the receptors (SSTR1, 2, 4, and 5) induce cell cycle arrest via PTP-dependent modulation of MAPK, associated with induction of the retinoblastoma tumor suppressor protein and p21. In contrast, SSTR3 uniquely triggers PTP-dependent apoptosis accompanied by activation of p53 and the pro-apoptotic protein Bax. SSTR1, 2, 3, and 5 display acute desensitization of adenylyl cyclase coupling. Four of the subtypes (SSTR2, 3, 4, and 5) undergo rapid agonist-dependent endocytosis. SSTR1 fails to be internalized but is instead upregulated at the membrane in response to continued agonist exposure. Among the wide spectrum of SST effects, several biological responses have been identified that display absolute or relative subtype selectivity. These include GH secretion (SSTR2 and 5), insulin secretion (SSTR5), glucagon secretion (SSTR2), and immune responses (SSTR2).

References (234)

  • MG Cattaneo et al.

    A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines

    FEBS Lett

    (1996)
  • L Chen et al.

    Both overlapping and distinct signalling pathways for somatostatin receptor subtype SSTR1 and SSTR2 in pituitary cells

    J Biol Chem

    (1997)
  • JD Corness et al.

    A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides

    FEBS Lett

    (1993)
  • J CW Finley et al.

    The immunocytochemical localization of somatostatin-containing neurons in the rat central nervous system

    Neurosci

    (1981)
  • VD Fitz-Patrick et al.

    Six agonist selectivity determinants in somatostatin receptor subtypes I and II

    J Biol Chem

    (1994)
  • CA Flanagan et al.

    Glutamate 301 of the mouse gonadotrophin releasing hormone receptor confers specificity for arginine 8 of mammalian gonadotrophin releasing hormone

    J Biol Chem

    (1994)
  • T Florio et al.

    Somatostatin inhibits PC C13 thyroid cell proliferation through the modulation of phosphotyrosine phosphatase activity-impairment of the somatostatinergic effects by stable expression of EIA viral oncogene

    J Biol Chem

    (1996)
  • Y Fujii et al.

    Somatostatin receptor subtype SSTR2 mediates the inhibition of high voltage activated calcium channels by somatostatin and its analogue SMS201-995

    FEBS Lett

    (1994)
  • S Fukusumi et al.

    Identification and characterization of a novel human corticostatin like peptide

    Biochem Biophys Res Commun

    (1997)
  • U Gether et al.

    Binding epitopes for peptide and nonpeptide ligands on the NK1 (substance P) receptor

    Regul Pep

    (1993)
  • MT Greenwood et al.

    Sequence analysis of the 5′-flanking promoter region of the human somatostatin receptor 5

    Biochem Biophys Res Commun

    (1994)
  • MT Greenwood et al.

    Cloning of the gene encoding the human somatostatin receptor 2: Sequence analysis of the 5′ flanking promoter region

    Gene

    (1995)
  • F Hauser et al.

    Sequence analysis of the promoter region of the rat somatostatin receptor subtype 1 gene

    FEBS Lett

    (1994)
  • L Helboe et al.

    Development of selective antibodies against the human somatostatin receptor subtypes SST1–SST5

    Mol Brain Res

    (1997)
  • G Hervieu et al.

    The localization of somatostatin receptor 1 (sst1) immunoreactivity in the rat brain using an N-terminal specific antibody

    Neuroscience

    (1998)
  • MT Hierowski et al.

    Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer Mia PaCA-2 cell line

    FEBS Lett

    (1985)
  • RW Hipkin et al.

    Agonist-induced desensitization, internalization and phosphorylation of the sst2A somatostatin receptor

    J Biol Chem

    (1997)
  • SA Hjorth et al.

    Identification of peptide binding residues in the extracellular domains of the AT1 receptor

    J Biol Chem

    (1994)
  • C Hou et al.

    Subtype-specific signalling mechanisms of somatostatin receptors SSTR1 and SSTR2

    J Biol Chem

    (1994)
  • D Hoyer et al.

    Classification and nomenclature of somatostatin receptors

    Trends Pharmacol Sci

    (1995)
  • N Hukovic et al.

    The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase, and in mediating desensitization and internalization

    J Biol Chem

    (1998)
  • BP Jung et al.

    Discovery of a novel human G protein coupled receptor gene (GPR25) located on chromosome 1

    Biochem Biophys Res Commun

    (1997)
  • BD Koch et al.

    Characterization of the cyclic AMP-independent actions of somatostatin in GH cells

    J Biol Chem

    (1988)
  • K Komatsuzaki et al.

    A novel system that reports the G-proteins linked to a given receptor: A study of type 3 somatostatin receptor

    FEBS Lett

    (1997)
  • H Kong et al.

    Differential expression of messenger RNAs for somatostatin receptor subtypes SSTR1, SSTR2, and SSTR3 in adult rat brain: Analysis by RNA blotting and in situ hybridization histochemistry

    Neuroscience

    (1994)
  • J Kraus et al.

    Alternative promoter usage and tissue specific expression of the mouse somatostatin receptor 2 gene

    FEBS Lett

    (1998)
  • HJ Kreienkamp et al.

    Coupling of rat somatostatin receptor subtypes to a G-protein gated inwardly rectifying potassium channel (GIRK1)

    FEBS Lett

    (1997)
  • MC Aguila

    Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase

    Proc Natl Acad Sci USA

    (1994)
  • MC Aguila et al.

    Evidence that somatostatin is localized and synthesized in lymphoid organs

    Proc Natl Acad Sci USA

    (1991)
  • MC Aguila et al.

    Somatostatin antisense oligodeoxynucleotide-mediated stimulation of lymphocyte proliferation in culture

    Endocrinology

    (1996)
  • M Amherdt et al.

    Selective binding of somatostatin-14 and somatostatin-28 to islet cells revealed by quantitative electron microscopic autoradiography

    J Clin Invest

    (1987)
  • M Amherdt et al.

    Binding and internalization of somatostatin, insulin, and glucagon by cultured rat islet cells

    J Clin Invest

    (1989)
  • RT Bass et al.

    Identification and characterization of novel somatostatin antagonists

    Mol Pharmacol

    (1996)
  • H Baumeister et al.

    Cloning, expression, pharmacology and tissue distribution of the mouse somatostatin receptor subtype 5

    J Neuroendocrinol

    (1998)
  • M Berelowitz et al.

    Effects of growth hormone excess and deficiency on hypothalamic somatostatin content and release and on tissue somatostatin distribution

    Endocrinology

    (1981)
  • M Berelowitz et al.

    Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary

    Science

    (1981)
  • AM Blum et al.

    Granuloma T lymphocytes in murine schistosomiasis mansoni have somatostatin receptors and respond to somatostatin with decreased IFN-γ secretion

    J Immunol

    (1992)
  • P Brazeau et al.

    Hypothalamic peptide that inhibits the secretion of immunoreactive pituitary growth hormone

    Science

    (1973)
  • CD Breder et al.

    Differential expression of somatostatin receptor subtypes in brain

    J Neurosci

    (1992)
  • T AL Brevini et al.

    Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer cell line LNCaP: Possible mechanism of action

    J Clin Endocrinol Metab

    (1993)
  • Cited by (0)

    View full text